Resultado final
Data management and validation plan final To facilitate the obligation to make research data available within 30 days following guidelines for H2020 projects working on COVID19 available at httpseuYh49yCProtection of personal data1 The consortium must ensure that the following is addressed in the Data Management Plana detailed information on the specific data protection informed consent procedures in regard to data processing must be provided prior to the start of the research activity raising ethics issue in case this is not addressed in the informed consent procedures for human participantsb the consortium must confirm that the specific data protection informed consent forms and information sheets in language and terms intelligible to the participants are kept on file in case this is not addressed in the informed consent procedures for human participants They must be provided to IMI JU upon request2 Details on the data which will be collected during the phone call at Day 28 within Clinical Study 1 CT p 6 must be provided
Data management and validation plan M12Data management and validation plan M12 To facilitate the obligation to make research data available within 30 days following guidelines for H2020 projects working on COVID19 available at httpseuYh49yCProtection of personal data1 The consortium must ensure that the following is addressed in the Data Management Plana detailed information on the specific data protection informed consent procedures in regard to data processing must be provided prior to the start of the research activity raising ethics issue in case this is not addressed in the informed consent procedures for human participantsb the consortium must confirm that the specific data protection informed consent forms and information sheets in language and terms intelligible to the participants are kept on file in case this is not addressed in the informed consent procedures for human participants They must be provided to IMI JU upon request2 Details on the data which will be collected during the phone call at Day 28 within Clinical Study 1 CT p 6 must be provided
Data management and validation planDMPs should cover strategy for all data in the project and how they can be made available as from the rules 30days Protection of personal data1 The consortium must ensure that the following is addressed in the Data Management Plana detailed information on the specific data protection informed consent procedures in regard to data processing must be provided prior to the start of the research activity raising ethics issue in case this is not addressed in the informed consent procedures for human participantsb the consortium must confirm that the specific data protection informed consent forms and information sheets in language and terms intelligible to the participants are kept on file in case this is not addressed in the informed consent procedures for human participants They must be provided to IMI JU upon request2 Details on the data which will be collected during the phone call at Day 28 within Clinical Study 1 CT p 6 must be provided
'IV imatinib in severe Covid-19' study peer reviewed publicationIV imatinib in severe Covid19 study peer reviewed publication submitted for review
'Oral imatinib in severe Covid-19' study peer reviewed publicationPeer reviewed publication reporting findings from the oral Phase II clinical study
Presentation of 'IV imatinib in severe Covid-19' study result at ERS, ESICM and ATS congressesPreparation of an abstract for presentation of IV imatinib in severe Covid19 study result at an international conference eg ATS
Pathophysiology report & manuscriptreport and manuscript for publication describing pathophysiology findings from the oral phase II clinical study
Public presentations of findings from the oral Phase II clinical study
Publicaciones
Autores:
J. De Brabander 1, E. Duijvelaar 4, J.R. Schippers 4, P.J. Smeele 4, J. Duitman 3, J. Aman 4, H.J. Bogaard 4, T. van der Poll 1, L.D.J. Bos 2, CounterCOVID Study Group
Publicado en:
American Thoracic Society International Conference Abstracts, 2022
Editor:
American Thoracic Society
DOI:
10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5049
Autores:
J. Schippers, E. Duijvelaar, P. Smeele, M. De Raaf, S. Blok, A. Vanhove, F. De Man, H. J. Bogaard, J. Aman
Publicado en:
American Thoracic Society International Conference Abstracts, 2022
Editor:
American Thoracic Society
DOI:
10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5048
Autores:
Jurjan Aman, Erik Duijvelaar, Liza Botros, Azar Kianzad, Job Schippers, Patrick Smeele, Sara Azhang, Imke Bartelink, Pierre Bet, Wim Boersma, Karin Boomars, Peter Bonta, Lieuwe Bos, Job Van Bragt, Gert-Jan Braunstahl, Lucas Celant, Katrien Eger, Miranda Geelhoed, Yurika Van Glabbeek, Hans GrotjohanShow lessLaura Hagens, Chris Happe, Leo Heunks, Michel Van Den Heuvel, Wouter Hoefsloot, Rianne Hoek,
Publicado en:
European Respiratory Journal, 2021
Editor:
European Respiratory Society
DOI:
10.1183/13993003.congress-2021.oa4119
Autores:
Jurjan Aman, Erik Duijvelaar, Liza Botros, Azar Kianzad, Job R Schippers, Patrick J Smeele, Sara Azhang, Imke H Bartelink, Ahmed A Bayoumy, Pierre M Bet, Wim Boersma, Peter I Bonta, Karin A T Boomars, Lieuwe D J Bos, Job J M H van Bragt, Gert-Jan Braunstahl, Lucas R Celant, Katrien A B Eger, J J Miranda Geelhoed, Yurika L E van Glabbeek, Hans P Grotjohan, Laura A Hagens, Chris M Happe, Boaz D Haze
Publicado en:
The Lancet Respiratory Medicine, Edición 9/9, 2021, Página(s) 957-968, ISSN 2213-2600
Editor:
Elsevier Limited
DOI:
10.1016/s2213-2600(21)00237-x
Autores:
Erik Duijvelaar; Job R Schippers; Patrick J Smeele; Michiel Alexander de Raaf; Arthur L E M Vanhove; Siebe G Blok; CounterCOVID Collaborative Group; Jos W R Twisk; Anton Vonk Noordegraaf; Frances S de Man; Harm Jan Bogaard; Jurjan Aman
Publicado en:
The Lancet Respiratory Medicine, Edición 22132600, 2022, ISSN 2213-2600
Editor:
Elsevier Limited
DOI:
10.1016/s2213-2600(22)00052-2
Autores:
Leila Atmowihardjo, Job R. Schippers, Imke H. Bartelink, Pierre M. Bet, Nienke van Rein, Keith Purdy, David Cavalla, Valérie Comberiati, Andrew McElroy, Sue D. Snape, Harm Jan Bogaard, Leo Heunks, Nicole Juffermans, Marcus Schultz, Pieter R. Tuinman, Lieuwe D. J. Bos & Jurjan Aman
Publicado en:
Trials, Edición 17456215, 2022, ISSN 1745-6215
Editor:
BioMed Central
DOI:
10.1186/s13063-022-06055-9
Autores:
Justin de Brabander, Erik Duijvelaar, Job R. Schippers, Patrick J. Smeele, Hessel Peters-Sengers, Jan Willem Duitman, Jurjan Aman, Harm J. Bogaard, Tom van der Poll, Lieuwe D.J. Bos on behalf of the CounterCOVID study group
Publicado en:
European Respiratory Journal, Edición 13993003, 2022, ISSN 1399-3003
Editor:
European Respiratory Society
DOI:
10.1183/13993003.00780-2022
Autores:
Imke H. Bartelink, Pierre M. Bet, Nicolas Widmer, Monia Guidi, Erik Duijvelaar, Bram Grob, Richard Honeywell, Amanda Evelo, Ivo P. E. Tielbeek, Sue D. Snape, Henrike Hamer, Laurent A. Decosterd, Harm Jan Bogaard, Jurjan Aman, Eleonora L. Swart
Publicado en:
CPT: Pharmacometrics & Systems Pharmacology, Edición 5 October 2021, 2021, ISSN 2163-8306
Editor:
Nature Publishing Group
DOI:
10.1002/psp4.12718
Buscando datos de OpenAIRE...
Se ha producido un error en la búsqueda de datos de OpenAIRE
No hay resultados disponibles